Hydroxypyruvic acid lithium hydrate Size:Contact [email protected] for quotation InChi: InChI=1S/C21H18O12/c22-8-4-10(24)15-11(25)6-12(31-14(15)5-8)7-1-2-9(23)13(3-7)32-21-18(28)16(26)17(27)19(33-21)20(29)30/h1-6

InChi: InChI=1S/C21H18O12/c22-8-4-10(24)15-11(25)6-12(31-14(15)5-8)7-1-2-9(23)13(3-7)32-21-18(28)16(26)17(27)19(33-21)20(29)30/h1-6

InChiKey: DUWPGRAKHMEPCM-IZZDOVSWSA-N

as it cannot be excreted from the body in its SN-38 form

A significant reduction in the death rate of infant mice infected with ten LD50) of coxsackievirus A16 is observed when they are treated 58 h after infection with two injections of Guanidine hydrochloride at 145 mg/kg per injection

ML265: A potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model

Hydroxypyruvic acid lithium hydrate Size:Contact [email protected] for quotation InChi: InChI=1S/C21H18O12/c22-8-4-10(24)15-11(25)6-12(31-14(15)5-8)7-1-2-9(23)13(3-7)32-21-18(28)16(26)17(27)19(33-21)20(29)30/h1-6Hydroxypyruvic acid lithium hydrate ( Hydroxypyruvic acid lithium hydrate) is an intermediate in the metabolism of glycine, serine and threonine. Hydroxypyruvic acid lithium hydrate is a substrate for serine pyruvate aminotransferase and glyoxylate reductase hydroxypyruvate reductase. Hydroxypyruvic acid lithium hydrate is involved in the metabolic disorder which is the dimethylglycine dehydrogenase deficiency pathway. Product information CAS Number: